Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd.

303.30
ILA
-2.70
(-0.88%)
5.68BMarket Cap
Apr 01Next Earn

Latest Stock Split

Jan 05, 2026

1:3000

For every 3000 shares held, investors received 1. The price per share adjusted from $1.00 to $3000.00.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Jan 05, 2026
    Before$1.00
    Split ratio1:3000
    After$3000.00
    Reverse
  2. May 12, 2013
    Before—
    Split ratio1:25
    After—
    Reverse

About Can-Fite BioPharma Ltd. stock splits

Can-Fite BioPharma Ltd. (TASE:CANF) operates in the Pharmaceuticals: major industry.

Can-Fite BioPharma Ltd. company overview

When did Can-Fite BioPharma Ltd. stock split?

Can-Fite BioPharma Ltd.'s most recent stock split was on January 5, 2026. It was a 1-for-3000 reverse split, so shareholders received 1 share for every 3000 they held.

What is Can-Fite BioPharma Ltd.'s stock split history?

Can-Fite BioPharma Ltd. (TASE:CANF) has split its stock 2 times: a 1-for-25 reverse split on May 12, 2013 and a 1-for-3000 reverse split on January 5, 2026.

How many times has Can-Fite BioPharma Ltd. stock split?

Can-Fite BioPharma Ltd. has split its stock 2 times. This history records 2 reverse splits between May 12, 2013 and January 5, 2026.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Can-Fite BioPharma Ltd.'s 1-for-3000 reverse split on January 5, 2026, every 3000 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Can-Fite BioPharma Ltd. split its stock again?

Can-Fite BioPharma Ltd. has not announced a new split in our records. Its most recent split was on January 5, 2026, less than a year ago. Companies announce splits in advance, and any new TASE:CANF split will appear on this page.